Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $14.11 million. The enterprise value is $9.92 million.

Market Cap	14.11M
Enterprise Value	9.92M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 3.17 million shares outstanding. The number of shares has increased by 19.08% in one year.

Shares Outstanding	3.17M
Shares Change (YoY)	+19.08%
Shares Change (QoQ)	+3.33%
Owned by Insiders (%)	28.35%
Owned by Institutions (%)	10.75%
Float	2.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	0.17
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.41
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.01.

Current Ratio	2.73
Quick Ratio	2.52
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.80% and return on invested capital (ROIC) is -146.91%.

Return on Equity (ROE)	-103.80%
Return on Assets (ROA)	-83.90%
Return on Capital (ROIC)	-146.91%
Revenue Per Employee	n/a
Profits Per Employee	-$482,378
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.14% in the last 52 weeks. The beta is 0.92, so Edesa Biotech's price volatility has been similar to the market average.

Beta (1Y)	0.92
52-Week Price Change	-41.14%
50-Day Moving Average	4.61
200-Day Moving Average	4.75
Relative Strength Index (RSI)	49.94
Average Volume (30 Days)	13,219

Short Selling Information

The latest short interest is 19,495, so 0.61% of the outstanding shares have been sold short.

Short Interest	19,495
Short Previous Month	17,726
Short % of Shares Out	0.61%
Short % of Float	0.84%
Short Ratio (days to cover)	1.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.70M
Pretax Income	-7.72M
Net Income	-7.72M
EBITDA	-7.52M
EBIT	-7.72M
Earnings Per Share (EPS)	-$2.63

Full Income Statement

Balance Sheet

The company has $4.27 million in cash and $78,314 in debt, giving a net cash position of $4.19 million or $1.32 per share.

Cash & Cash Equivalents	4.27M
Total Debt	78,314
Net Cash	4.19M
Net Cash Per Share	$1.32
Equity / Book Value	5.84M
Book Value Per Share	1.84
Working Capital	3.43M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.25M
Capital Expenditures	n/a
Free Cash Flow	-6.25M
FCF Per Share	-$2.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.08%
Shareholder Yield	-19.08%
Earnings Yield	-54.68%
FCF Yield	-44.29%

Analyst Forecast

The average price target for Edesa Biotech is $39.00, which is 776.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.00
Price Target Difference	776.40%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 1:7.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1